Trial intelligence / Profile preview

STEPS study in pulmonary sarcoidosis

NL-OMON44859Recruiting

Sponsor
Erasmus MC
Start
Dec 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of prednisone in pulmonary sarcoidosis and sarcoidosis, sponsored by Erasmus MC. Primary endpoint: Repeated measurements of forced vital capacity and prednisone dose used. Started Dec 2013; status: recruiting.

02

Drugs

prednisone
03

Conditions

pulmonary sarcoidosissarcoidosis

Beyond the preview

Go deeper on NL-OMON44859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call